1 paper · 1 filter
Fariba Tohidinezhad, Douwe J. Spaanderman, Natalia Oviedo Acosta +14
Background: Response to neoadjuvant imatinib in gastrointestinal stromal tumors (GISTs) is highly variable and cannot be reliably predicted using current clinical or molecular mark…